After Alzheimer's drug flop, Peninsula biotech's founding execs exit
The company said it will try again with the failed drug, this time as a treatment for a type of head and neck cancer.
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Ron Leuty Source Type: news
More News: Alzheimer's | Biotechnology | Cancer | Cancer & Oncology | Head and Neck Cancer | Health Management